| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |